LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the Middle East. Read More
| Price | 64.50p on 28-08-2026 at 17:35:08 |
|---|---|
| Change | 2.00p 3.2% |
| Buy | 67.00p |
| Sell | 62.00p |
| Last Trade: | Unknown 100,000.00 at 64.00p |
| Day's Volume: | 248,494 |
| Last Close: | 64.50p |
| Open: | 62.50p |
| ISIN: | GB00B0BRN552 |
| Day's Range | 62.50p - 64.50p |
| 52wk Range: | 57.00p - 128.00p |
| Market Capitalisation: | £49.70m |
| VWAP: | 63.79748p |
| Shares in Issue: | 77.05m |
Sector: Software and Computing
Listed In: FTSE AIM All-Share,
Bango (BGO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 100,000 | 64.00p | Ordinary |
16:24:58 - 28-Aug-26 |
| Sell* | 478 | 64.21p | Ordinary |
15:01:13 - 28-Aug-26 |
| Buy* | 4,100 | 66.00p | Ordinary |
14:08:33 - 28-Aug-26 |
| Buy* | 634 | 65.25p | Ordinary |
14:02:28 - 28-Aug-26 |
| Sell* | 7 | 64.21p | Ordinary |
13:55:03 - 28-Aug-26 |
| Sell* | 5,502 | 64.21p | Ordinary |
12:59:13 - 28-Aug-26 |
| Sell* | 2,751 | 64.21p | Ordinary |
12:52:10 - 28-Aug-26 |
| Buy* | 500 | 65.25p | Ordinary |
11:20:21 - 28-Aug-26 |
| Buy* | 4,900 | 65.00p | Ordinary |
11:07:19 - 28-Aug-26 |
| Buy* | 11,551 | 64.89p | Ordinary |
11:05:04 - 28-Aug-26 |
Bango (BGO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Aug 2026 4:20 pm | RNS | Holding(s) in Company |
| 5th Aug 2026 4:20 pm | RNS | Holding(s) in Company |
| 31st Jul 2026 5:36 pm | RNS | Director/PDMR Shareholding |
| 17th Jul 2026 5:22 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 9th Jul 2026 7:00 am | RNS | 1H26 Trading Statement |
| 26th Jun 2026 7:00 am | RNS | Directorate change |
| 25th Jun 2026 4:18 pm | RNS | Result of AGM |
| 25th Jun 2026 8:00 am | RNS-R | Turkcell select Bango for subscription bundling |
| 22nd Jun 2026 2:17 pm | RNS | Director/PDMR Shareholding |